Neoplasm, Colorectal
7
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
Endoscopic Submucosal Dissection Registry
Gut Microbiome in Colorectal Cancer
Predicting Risk for Post-polypectomy Colorectal Cancer